Clinical trials are currently recruiting patients for lncRNA-based cancer diagnosis (https://clinicaltrials.gov/ct2/show/NCT03830619 accessed on 5 February 2019 https://clinicaltrials.gov/ct2/show/NCT04269746 accessed on 8 July 2020) and the lncRNA PCA3 was also clinically approved for cancer diagnosis [170]. The gene discussed is PCA3; the disease is cancer.